Bupivacaine Hydrochloride, E · 3,125 days since initial FDA posting
Brand: SENSORCAINE MPF
FDA lists Bupivacaine Hydrochloride, E as Active Shortage (Fresenius Kabi USA, LLC).
Availability on file: Available
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
- Manufacturer
- Fresenius Kabi USA, LLC
- Dosage Form
- Injection
- Presentation
- Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-17)
- Package NDC
- 63323-462-17
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Feb 20, 2018
- Last Updated
- Mar 17, 2026
- Therapeutic Category
- Anesthesia
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Check wholesalers for inventory
Nearby, Other Bupivacaine Shortage Records
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
Fresenius Kabi USA, LLC
Injection
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
Fresenius Kabi USA, LLC
Injection
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
Fresenius Kabi USA, LLC
Injection
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
Fresenius Kabi USA, LLC
Injection
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
Fresenius Kabi USA, LLC
Injection
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
Fresenius Kabi USA, LLC
Injection
FDA reason on file: Check wholesalers for inventory. General shortage guidance lives on the tracker hub.